Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-059044)

Filing Details

Accession Number:: 0001209191-18-059044
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-16 17:56:38
Reporting Period:: 2018-11-16

Accepted Time:: 2018-11-16 17:56:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1124105	Catalyst Biosciences Inc.	CBIO	Pharmaceutical Preparations (2834)	562020050

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1672333	Howard Levy	611 Gateway Boulevard, Suite 710 South San Francisco CA 94080	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-11-16	173	$4.63	7,733	No	4	M	Direct
Common Stock	Disposition	2018-11-16	173	$11.00	7,560	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-11-16	173	$0.00	173	$4.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
87,267		2027-07-11	No	4	M	Direct

Footnotes

Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on September 5, 2018.
The Option vests monthly over a period of four years commencing June 15, 2017.